POEM-F for Achalasia International Study

Recruiting N/A Interventional Study
Achalasia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
81 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in up to 50-60% of patients. In order to reduce the risk of GERD, endoscopic fundoplication has been dev…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. Adult patient (age ≥18 and ≤65 years-old) and with symptomatic achalasia type I or II. 2. Capability of understanding and complying with the study requirements, including filling the Eckardt Score, GERD-HRQL and RSI questionnaire and signing the informed consent form. 3. Pati…
Contacts

Hon Chi Yip, FRCSEd

35052627

hcyip@surgery.cuhk.edu.hk

CONTACT